MIAMI, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, announced today that it will report its 2023 financial results after the market close on February 27, 2024. The Company will host a conference call at 5:00 p.m. ET that day to discuss the Company's results and provide a business update.
Title | Longeveron Full Year 2023 Results Conference Call |
Date | 2/27/2024 |
Time | 5 PM Eastern Time |
Conference Call Details | 1-877-407-0789 |